Celltrion Is To Invest $33.6bn As It Lays Out Long-Term Ambitions

Celltrion unveils massive long-term investment plan to secure leadership in the global biopharma market, set up international sales distribution networks and support new bioventures and job creation, in the meantime contributing to Korea’s larger ambitions to develop as a worldwide drug industry hub.

Celltrion_Magnified
Celltrion Unveils Huge Investment Plan For Global Ambitions • Source: Shutterstock

Celltrion Inc., which has recently announced plans to establish its own global direct sales and distribution networks to seek further growth and improve margins, aims to invest a massive KRW40tn ($33.6bn) over the next 10 years in both biologics and chemical drugs, and in worldwide healthcare and U-healthcare (ubiquitous healthcare) platform businesses under a new long-term road map.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Biosimilars

More from Products